Cite
HARVARD Citation
Goekkurt, E. et al. (n.d.). 778TiPIpilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): The randomized phase II INTEGA trial (AIO STO 0217). Annals of oncology. p. . [Online].